Somatic Health Partners with Kinetisense to Expand AI-Powered MSK Solutions for Employers and Providers

San Francisco — September 6, 2024 — Somatic Health, a pioneer in AI-driven musculoskeletal (MSK) injury prevention and rehabilitation technology, is excited to announce a new strategic partnership with Kinetisense. Kinetisense is the world's first patented sensorless motion capture analysis system, providing clinical quality MSK health screenings for employees, patients and other consumers. Integrating the Kinetisense 3D assessment technology into Somatic Health's advanced digital rehabilitation platform will create a comprehensive MSK solution offering a full care program from movement screening to coordinated virtual and in- clinic consultations for employers and providers globally.

Revolutionizing MSK Care with AI and Telehealth

Combining Somatic's cutting-edge AI-powered injury prevention tool, national on-demand virtual and in-clinic PT network, and remote therapeutic monitoring (RTM) services with the Kinetisense 3D movement assessment technology will prevent injuries, streamline return-to- work for employees, and improve patient outcomes. Practitioners and employers alike will benefit from this comprehensive solution providing immediate access to virtual care, seamless scheduling, rapid access to a nationwide PT network, and continuous patient monitoring. This approach will increase employee productivity and reduce healthcare spending.

Clinicians will now have a full-scale evidence-based approach to objectively assess their patients and track functional progress beyond patient care discharge. The data-driven outputs of the Kinetisense and Somatic systems will enhance objectivity and efficiency while improving patient care and clinical outcomes.

Expanding Nationwide Access and Capabilities

According to Somatic CEO Dr. Tony Zhang, “With Somatic Health's hybrid 'online + clinic' model, both Somatic and Kinetisense will help individuals assess their risk of falls and other injuries, and receive MSK care early and continuously”. The partnership will integrate the 3D MSK assessment results with Somatic's thousands of personalized home exercise programs. Additionally, the integration of Somatic's MoveGPT technology will allow employees and patients to gain AI-based insights into their conditions and access to professional health support swiftly. CEO and Co-Founder of Kinetisense Dr. Ryan Comeau states that “the shortcomings that our clinical and workplace ecosystems have had to endure due to the lack of evidence- based care are significant. This partnership changes the way that we assess our patients and employees, and provides the full spectrum of data-driven care. This combined solution will improve clinical/employee wellness outcomes, enhance efficiencies and augment the clinical and employee wellness pathways.”

About Somatic Health

Somatic's AI-enabled platform combines prevention, early intervention, and user engagement to prevent injuries and accelerate recovery for MSK and associated chronic conditions for employees and patients. The Somatic virtual and in-clinic model is based on scientific evidence showing that clinician-led treatment augmented by precision digital technology creates a more engaged employee and patient experience, leading to demonstrably improved outcomes, lower MSK-related costs and reduced incidence of injuries.

About Kinetisense

As the world's first patented sensorless motion capture analysis system, Kinetisense provides real-time biofeedback on how employees and patients truly move. The proprietary AI-driven “Kinetisense 3D Mocap Engine” provides a biomechanic lab level of accuracy on the iPad Pro. Kinetisense is considered the world leader in human movement analysis and is sold in over 25 countries in the following markets: Employee Wellness, Clinical, Tactical, Senior Living, and Sports Performance.